Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ercon is a privately held U.S. manufacturer of conductive polymer thick-film inks and coating materials used in diagnostic electrodes, electrochemical biosensors, and related printed electronic applications. Its products are used by medical diagnostics and device manufacturers, including in blood-glucose test strips and body electrodes, and the company also serves non-healthcare end markets such as RFID, touch screens, membrane switches, force sensors, and EMI shielding. The business appears to operate as a commercial materials and component supplier rather than a drug developer, with core capabilities in silver, silver/silver chloride, carbon, graphite, platinum, gold, and insulating ink systems. Within healthcare, Ercon's relevance is primarily in enabling diagnostic sensor manufacturing rather than developing therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ercon.